Author:
Diener Hans-Christoph,Nickenig Georg,Forsting Michael,Goldbrunner Roland
Reference23 articles.
1. Ahmadi M, Laumeier I, Ihl T, Steinicke M, Ferse C, Endres M, et al. A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial. Lancet Neurol. (2019).
2. Campbell BCV, Ma H, Ringleb PA, Parsons MW, et al. Extend Investigators. Extending thrombolysis to 4.5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet 394 (10193) (2019) 139–147.
3. Chen ZM, Sandercock P, Pan HC et al.: Indications for early aspirin use in acute ischemic stroke. A combined analysis of 40,000 randomized patients from the Chinese acute stroke trial and the International stroke trial. Stroke 31 (2000) 1240–1249.
4. Connolly SJ, Ezekowitz MD, Yusuf S et al.: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361 (2009) 1139–1151.
5. Diener HC, Hankey GJ: Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar. J Am Coll Cardiol. 75(15) (2020) 1804–1818.